Autism spectrum disorder: co-morbid symptoms management

Dr. Harvinder Singh February 26, 2019

Autism spectrum disorder is a neurodevelopmental disorder characterized by deficits in social communication and social reciprocity, as well as repetitive behavior and restricted interests.

(Q.1): Which of the following stimulant is shown to have negative net benefit score (benefit minus adverse) in autism spectrum disorder?

(Q.2): Which of the following antipsychotics is shown to have better net benefit score (benefit minus adverse) in patients with autism spectrum disorder (compared to other antipsychotics)?

(Q.3): Which of the following statement is not correct regarding the use of psychotropic medications in patients with autism spectrum disorder (ASD)?

↓

↓

Answers:

(1): (d) amphetamine/ dextroamphetamine (Adderall)

(2): (a) risperidone

(3): (c) There are no FDA approved medications for autism related irritability. 

Answer with detailed explanation available in course:
(for course subscribers only) ==>

https://psychiatryeducationforum.teachable.com/courses/physicians-guide-for-clinical-psychiatry/lectures/9287551
A

Dr. Harvinder Singh, M.D.

(Admin & Course Instructor)

Enroll in course to access similar clinically relevant psychiatry topics:

Click Here to Enroll in Course

Share
Categories: Psycho-Pharmacology
Tagged:

Related Articles